Literature DB >> 29626981

Placental lipoprotein lipase activity is positively associated with newborn adiposity.

Margaret J R Heerwagen1, Diane L Gumina2, Teri L Hernandez3, Rachael E Van Pelt4, Anita W Kramer2, Rachel C Janssen5, Dalan R Jensen6, Theresa L Powell1, Jacob E Friedman7, Virginia D Winn2, Linda A Barbour8.   

Abstract

INTRODUCTION: Recent data suggest that in addition to glucose, fetal growth is related to maternal triglycerides (TG). To reach the fetus, TG must be hydrolyzed to free fatty acids (FFA) and transported across the placenta, but regulation is uncertain. Placental lipoprotein lipase (pLPL) hydrolyzes TG, both dietary chylomicron TG (CM-TG) and very-low density lipoprotein TG (VLDL-TG), to FFA. This may promote fetal fat accretion by increasing the available FFA pool for placental uptake. We tested the novel hypothesis that pLPL activity, but not maternal adipose tissue LPL activity, is associated with newborn adiposity and higher maternal TG.
METHODS: Twenty mothers (n = 13 normal-weight; n = 7 obese) were prospectively recruited. Maternal glucose, insulin, TG (total, CM-TG, VLDL-TG), and FFA were measured at 14-16, 26-28, and 36-37 weeks, and adipose tissue LPL was measured at 26-28 weeks. At term delivery, placental villous biopsies were immediately analyzed for pLPL enzymatic activity. Newborn percent body fat (newborn %fat) was assessed by skinfolds.
RESULTS: Placental LPL activity was positively correlated with birthweight (r = 0.48;P = 0.03) and newborn %fat (r = 0.59;P = 0.006), further strengthened by correcting for gestational age at delivery (r = 0.75;P = 0.0001), but adipose tissue LPL was not. Maternal TG and BMI were not correlated with pLPL activity. Additionally, pLPL gene expression, while modestly correlated with enzymatic activity (r = 0.53;P < 0.05), was not correlated with newborn adiposity. DISCUSSION: This is the first study to show a positive correlation between pLPL activity and newborn %fat. Placental lipase regulation and the role of pLPL in pregnancies characterized by nutrient excess and fetal overgrowth warrant further investigation.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Fetal fat accretion; Fetal growth; Lipoprotein lipase; Newborn adiposity; Placenta; Triglycerides

Mesh:

Substances:

Year:  2018        PMID: 29626981     DOI: 10.1016/j.placenta.2018.03.001

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  20 in total

1.  Maternal Obesity and Western-Style Diet Impair Fetal and Juvenile Offspring Skeletal Muscle Insulin-Stimulated Glucose Transport in Nonhuman Primates.

Authors:  William Campodonico-Burnett; Byron Hetrick; Stephanie R Wesolowski; Simon Schenk; Diana L Takahashi; Tyler A Dean; Elinor L Sullivan; Paul Kievit; Maureen Gannon; Kjersti Aagaard; Jacob E Friedman; Carrie E McCurdy
Journal:  Diabetes       Date:  2020-04-30       Impact factor: 9.461

2.  Maternal Lipids and Fetal Overgrowth: Making Fat from Fat.

Authors:  Linda A Barbour; Teri L Hernandez
Journal:  Clin Ther       Date:  2018-09-18       Impact factor: 3.393

3.  No evidence of attenuation of placental insulin-stimulated Akt phosphorylation and amino acid transport in maternal obesity and gestational diabetes mellitus.

Authors:  Marisol Castillo-Castrejon; Thomas Jansson; Theresa L Powell
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-10-01       Impact factor: 4.310

4.  Cord blood metabolic markers are strong mediators of the effect of maternal adiposity on fetal growth in pregnancies across the glucose tolerance spectrum: the PANDORA study.

Authors:  I-Lynn Lee; Elizabeth L M Barr; Danielle Longmore; Federica Barzi; Alex D H Brown; Christine Connors; Jacqueline A Boyle; Marie Kirkwood; Vanya Hampton; Michael Lynch; Zhong X Lu; Kerin O'Dea; Jeremy Oats; H David McIntyre; Paul Zimmet; Jonathan E Shaw; Louise J Maple-Brown
Journal:  Diabetologia       Date:  2020-01-08       Impact factor: 10.122

Review 5.  Nutrition therapy within and beyond gestational diabetes.

Authors:  Teri L Hernandez; Archana Mande; Linda A Barbour
Journal:  Diabetes Res Clin Pract       Date:  2018-04-19       Impact factor: 5.602

6.  Altered triglyceride and phospholipid metabolism predates the diagnosis of gestational diabetes in obese pregnancy.

Authors:  Samuel Furse; Sara L White; Claire L Meek; Benjamin Jenkins; Clive J Petry; Matias C Vieira; Susan E Ozanne; David B Dunger; Lucilla Poston; Albert Koulman
Journal:  Mol Omics       Date:  2019-12-02

Review 7.  Maternal Non-glycemic Contributors to Fetal Growth in Obesity and Gestational Diabetes: Spotlight on Lipids.

Authors:  Linda A Barbour; Teri L Hernandez
Journal:  Curr Diab Rep       Date:  2018-05-09       Impact factor: 4.810

8.  Association of Maternal DNA Methylation and Offspring Birthweight.

Authors:  Parnian Kheirkhah Rahimabad; Syed Hasan Arshad; John W Holloway; Nandini Mukherjee; Anna Hedman; Olena Gruzieva; Ellika Andolf; Juha Kere; Goran Pershagen; Catarina Almqvist; Yu Jiang; Su Chen; Wilfried Karmaus
Journal:  Reprod Sci       Date:  2020-08-04       Impact factor: 3.060

9.  Effect of type 2 diabetes mellitus on placental expression and activity of nutrient transporters and their association with birth weight and neonatal adiposity.

Authors:  Marisol Castillo-Castrejon; Kyohei Yamaguchi; Rachel L Rodel; Kathryn Erickson; Anita Kramer; Nicole M Hirsch; Kristy Rolloff; Thomas Jansson; Linda A Barbour; Theresa L Powell
Journal:  Mol Cell Endocrinol       Date:  2021-05-12       Impact factor: 4.369

10.  Fetal macrosomia in a Hispanic/Latinx predominant cohort and altered expressions of genes related to placental lipid transport and metabolism.

Authors:  Heqin Yang; Bin He; Chandra Yallampalli; Haijun Gao
Journal:  Int J Obes (Lond)       Date:  2020-06-03       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.